| Metric | შპს ნიუ ფარმა NEW PHARMA | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾2.32bn₾1.91bn |
| Revenue growth | -100.0% | 21.1% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | — |
| EBITDA margin | -29687.2%-11.6% | — |
| Net profit | -₾258k-₾726k | ₾1.33bn₾992.0m |
| Net margin | -29249.2%-17.7% | 57.6%51.9% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾31.39bn₾28.37bn |
| Total equity | -₾780k-₾522k | ₾4.45bn₾3.79bn |
| ROE | — | 30.0%26.2% |